News

Nature News&Comment 22/07/2017 21:00 Not enough attention has been paid to vaccines in the quest to beat drug-resistant infections: read the editorial  

Researchers at the University of Zaragoza (belonging to CIBERES) and the biopharmaceutical vaccine company Biofabri in Porrino, Spain, in partnership with the TuBerculosis Vaccine Initiative [...]

TBVI is pleased to announce the 3 winners of the young scientist award 2017. Each of these winners are outstanding scientist in the TB vaccine R&D field. TBVI wishes them a very successful [...]

Fundació Institut d’Investigació en Ciències de la Salut Germans Trias i Pujol, Unitat de Tuberculosi Experimental, is searching for a post-doc (or 2) to apply to the Marie Curie [...]

The University of Zaragoza recently published a review on MTBVAC, where they describe the discovery history and its development under the umbrella of TBVI. You can find the full manuscript here.